Member Info for RegulatorUK

"It does need approval Chuggley. Surescreen have already got emergency approval as you have noted previously so looking good for immediate approval once the tests get through evaluation. Doesn't really make a difference now does it? "

I think people are getting a little confused over what approvals are required. Not unsurprising as much of the process has been made up on the fly by PHE and MHRA over the last year...

SureScreen has three antigen tests, all of which are CE marked for professional POC use only. One of those tests has also now been through the PHE assessment process which enables it to be purchased by HMG outside of an MHRA EUA.

Mologic has an antigen test, which is also CE marked for professional POC use only, and which is currently being TTd to ODX (who will then independently UKCA/CE mark it). As far as I am aware, this test is also in the PHE assessment process which, when complete (obviously assuming it passes) will enable it to be purchased by HMG outside of an MHRA EUA.

MHRA EUA only applies where the device is not CE marked and/or has not passed the PHE assessment.

"think you guys will be dissapointed - this is just share manipulation by trevor and his merrymen- outrageous but there u are- welcome to the corrupt world of braveheart and trevor brown !!! - un touchable sitting in switzerland screwing over as many people as he can -greed is ugly"

Someone clearly doesn't understand how investment funds like BRH operate and is a little butthurt as a result...

Edit: SureScreen also produce an IgG/IgM antibody test - but that too is professional POC only.

Sure Screen manufacture an antigen test - and have recently received a significant order from the government. SureSign would not be selling the antigen test other than for professional POC use.

SureSign is brand of CIGA Healthcare, which is part of the UK-RTC. They're marketing the AbC19 antibody test for professional POC use.

SureScreen and SureSign are two different companies with two different tests.

"It do what it always do.. Rise this afternoon you only have to look at yesterday fall and rise"

Hope so. I've just topped up.

That's a retrospective publication of an old antigen Contract award. It won't be ODX. It'll probably be Innova or Surescreen.

I'm hoping we'll have the usual morning burp... and I can top up cheaply.

Either that or I need to find a new home for my cash. Might grab a few more Abingdon.

"http://www.pennystockdream.com/Market-Maker-Signals"

It's nonsense.

"I thought the same but given the volumes required by the government, as stated in the times this morning its irrelevant. odx will sell all they can produce"

Yep. Anyone who can manufacture LFTs will be able to sell what they can produce.

*tweet not test. Damn autocorrect.

Your test is incorrect. Abingdon can manufacture LFTs (and will manufacture sovereign tests) and is publicly traded.

"I genuinely think it's laughable when people talk about CD4. This business was worth peanuts when it was a CD4 business..."

Errr... when was it a "CD4 business"?

The reality is the CD4 part of the business didn't really have a chance to take off before Covid 19 struck. Global Fund/UNITAID approval was in September 2019, subject to WHO prequalification, which only occurred in August 2020. This means that, other than the CHAI order, you wouldn't expect major CD4 sales until the new 2021 financial year for the relevant NGOs/IGOs.

Your post betrays your ignorance of the field...

Oh Lord... we haven't had the "wait until the US markets open" b0llock5 for a while...

"Here we. out crawl all the TB haters now.....

typical"

The RMS butthurt, who don't understand how investment companies such as BRH work, always like to whinge...

Not so much a speeding ticket as a reminder...

"RNS Number : 2549P
Braveheart Investment Group plc
16 February 2021

16 February 2021

Braveheart Investment Group plc

("Braveheart" or the "Group")

Share price movement

Braveheart notes the recent share price rise. On 29 January 2021 Braveheart provided an update concerning progress to develop a COVID-19 test that Paraytec Limited is working on in conjunction with the University of Sheffield.

In the update it was noted that the pipeline of clinical samples was now fully operational and additional staff had been recruited to process samples for performance assessment. The update also stated that the results from this phase of clinical testing were expected by the end of February and this remains the case. Until the results of the testing are known there can be no certainty that the tests will be successful.

A further announcement will be made in due course.

For further information:

Braveheart Investment Group plc

Tel: 01738 587555

Trevor Brown CEO

Allenby Capital Limited (Nominated Adviser and Joint Broker)

Tel: 020 3328 5656

David Worlidge / James Reeve / George Payne







Peterhouse Capital Limited (Joint Broker)

Tel: 020 7469 0936

Heena Karani / Lucy Williams"

"Does Bravehar have any connections to these companies."

No.

"You need a phD to decipher half of these!No wonder twitter is so rampant with rumours."

I think tecbadger has that PhD...

;-)

With an average of 24.3pps, I'm rather enjoying this morning...

"I dont like the secrecy about the COVID product. They are at validation but I've not seen design freeze or any large scale in house datasets for verification. We hear good performance but not the numbers....
...In summary I'm too wary to invest there however I watch with interest. Affirmer tech could be a gamechanger. Particularly in oncology."

It's what pees me off about Avacta. The constant flow of fluff RNS with no real substance.

Hopefully, their partnership with Mologic will allow them to actually get something finalised and over the line...